Tertiary lymphoid structures associated with enhanced anti-tumor immunity and favorable prognosis in cervical squamous carcinoma

被引:1
|
作者
Xiong, Guohai [1 ,2 ]
Shan, Jinmei [1 ,2 ]
Chong, Qingguo [1 ,2 ]
Cui, Yueqing [1 ,2 ]
机构
[1] Yancheng Third Peoples Hosp, Dept Gynaecol, Yancheng 224008, Peoples R China
[2] Nanjing Med Univ, Dept Gynaecol, Yancheng Sch Clin Med, Yancheng 224008, Peoples R China
来源
AGING-US | 2024年 / 16卷 / 08期
关键词
tertiary lymphoid structures; anti-tumor immunity; cervical cancer; prognosis; B-CELLS; IMMUNOTHERAPY; LANDSCAPE; REVEAL;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Cervical squamous carcinoma (CESC) is the main subtype of cervical cancer. Unfortunately, there are presently no effective treatment options for advanced and recurrent CESC. Tertiary lymphoid structures (TLSs) are clusters of lymphoid cells that resemble secondary lymphoid organs; nevertheless, there is no summary of the clinical importance of TLS in CESC. Methods: A large set of transcriptomic and single-cell RNA-sequencing (scRNA-seq) datasets were used to analyze the pattern of TLS and its immuno-correlations in CESC. Additionally, an independent in-house cohort was collected to validate the correlation between TLS and TME features. Results: In the current study, we found that the presence of TLS could predict better prognosis in CESC and was correlated with the activation of immunological signaling pathways and enrichment of immune cell subpopulations. In addition, TLS was associated with reduced proliferation activity in tumor cells, indicating the negative correlation between TLS and the degree of malignancy. Last but not least, in two independent immunotherapy cohorts, tumors with the presence of TLS were more sensitive to immunotherapy. Conclusion: Overall, TLS is related to an inflamed TME and identified immune-hot tumors, which could be an indicator for the identification of immunological features in CESC.
引用
收藏
页码:6898 / 6920
页数:23
相关论文
共 50 条
  • [21] Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer
    Overacre-Delgoffe, Abigail E.
    Bumgarner, Hannah J.
    Cillo, Anthony R.
    Burr, Ansen H. P.
    Tometich, Justin T.
    Bhattacharjee, Amrita
    Bruno, Tullia C.
    Vignali, Dario A. A.
    Hand, Timothy W.
    IMMUNITY, 2021, 54 (12) : 2812 - +
  • [22] INDUCTION OF TERTIARY LYMPHOID STRUCTURES IN NON-SMALL CELL LUNG CANCER IMPROVES B AND T CELL ANTI-TUMOR IMMUNITY
    Kim, Hye Mi
    Liu, Dongyan
    Ruffin, Ayana
    McDonough, Alexandra
    Lampenfeld, Caleb
    Kunning, Sheryl
    Somasundaram, Ashwin
    Stabile, Laura
    Bruno, Tullia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1180 - A1180
  • [23] Tertiary lymphoid structures restrain cancer evolution by supporting stemlike CD8+T cells for sustained anti-tumor immunity
    Wang, Pengxiang
    Zhou, Chi
    Wei, Zhiting
    Wang, Yue
    Gao, Yuli
    Meng, Fangliangzi
    Zhou, Jian
    Fan, Jia
    Liu, Qi
    Sun, Yunfan
    CANCER RESEARCH, 2024, 84 (06)
  • [24] Construction of a novel disulfidptosis-related lncRNAs signature for prognosis prediction and anti-tumor immunity in laryngeal squamous cell carcinoma
    Zhang, Min
    Sun, Qing
    Han, Zhijin
    Qin, Xuemei
    Gao, Tianle
    Xu, Yinwei
    Han, Shuhui
    Zhang, Yujie
    Liang, Qian
    Guo, Zhiqiang
    Liu, Jian
    HELIYON, 2024, 10 (10)
  • [25] Distinct maturity and spatial distribution of tertiary lymphoid structures in head and neck squamous cell carcinoma: implications for tumor immunity and clinical outcomes
    Xu, Shuai
    Han, Chao
    Zhou, Jian
    Yang, Di
    Dong, Hui
    Zhang, Yiwei
    Zhao, Tingting
    Tian, Yi
    Wu, Yuzhang
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (03)
  • [26] Tertiary lymphoid structures in head and neck squamous cell carcinoma
    Zhu, Jing
    Lu, Hui
    Wang, Kongcheng
    Liu, Baorui
    Yan, Jing
    TRANSLATIONAL ONCOLOGY, 2024, 44
  • [27] Enrichment of tertiary lymphoid structures provides novel insight into mediators of anti-tumor immune activity in sarcomatoid renal cell carcinoma
    Salgia, Nicholas
    Aubrecht, Wilhelm
    Attwood, Kristopher
    Chow, Jacky
    Eng, Kevin
    Wang, Jianmin
    Xu, Bo
    Long, Mark
    Kauffman, Eric
    Muhitch, Jason
    ONCOLOGIST, 2024, 29 : S9 - S10
  • [28] Expression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma
    Hong, Mun-Kun
    Wang, Jen-Hung
    Su, Cheng-Chuan
    Li, Ming-Hsun
    Hsu, Yung-Hsiang
    Chu, Tang-Yuan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (06) : 1247 - 1255
  • [29] Prognostic impact of Tertiary lymphoid structures (TLS) surrounding the tumor in esophageal squamous cell carcinoma
    Deguchi, Sota
    Tanaka, Hiroaki
    Mori, Takuya
    Nanbara, Mikio
    Miki, Yuichiro
    Iseki, Yasuhito
    Yoshii, Mami
    Fukuoka, Tatsunari
    Tamura, Tatsuro
    Shibutani, Masatsune
    Nagahara, Hisashi
    Toyokawa, Takahiro
    Lee, Shigeru
    Muguruma, Kazuya
    Ohira, Masaichi
    CANCER SCIENCE, 2021, 112 : 479 - 479
  • [30] CHARACTERISTICS OF SUPPRESSOR CELLS ASSOCIATED WITH ANTI-TUMOR IMMUNITY AND THEIR ELIMINATION LEADING TO ENHANCEMENT OF ANTI-TUMOR IMMUNITY
    KATAOKA, T
    SEIKAGAKU, 1982, 54 (03): : 139 - 150